April 1 (Reuters) - Acorda Therapeutics Inc ( ACOR ):

* ACORDA THERAPEUTICS AND MERZ ANNOUNCE SIGNING OF "STALKING

HORSE" ASSET PURCHASE AGREEMENT

* : ACORDA ENTERS INTO A RESTRUCTURING SUPPORT AGREEMENT

WITH OVER

90% OF SECURED CONVERTIBLE NOTEHOLDERS

* : PATIENT ACCESS TO INBRIJA(®) (LEVODOPA INHALATION

POWDER) AND

AMPYRA(® )(DALFAMPRIDINE) TO CONTINUE UNINTERRUPTED

* : ACORDA WILL CONTINUE OPERATIONS WHILE IT WORKS TO

COMPLETE

SALE PROCESS

* DEBTOR-IN-POSSESSION FINANCING AGREEMENT TO PROVIDE A TERM

LOAN

FACILITY IN AGGREGATE AMOUNT OF $20 MILLION IN NEW MONEY

* FILES FOR VOLUNTARY CHAPTER 11 PROTECTION TO FACILITATE

ORDERLY

SALE

* : ENTERED INTO AN ASSET PURCHASE AGREEMENT WITH MERZ

THERAPEUTICS TO PURCHASE ALL OF ASSETS OF ACORDA FOR $185

MILLION

Source text for Eikon:

Further company coverage: